查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1528071

全球冠状动脉支架市场

Coronary Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 342 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

至2030年，全球冠状动脉支架市场预计将达到130亿美元

2023年全球冠状动脉支架市场预计为89亿美元，预计到2030年将达到130亿美元，2023-2030年分析期间复合年增长率为5.5%。药物释放型支架是本报告分析的细分市场之一，预计复合年增长率为 5.7%，到分析期结束时将达到 92 亿美元。分析期间其他类型细分市场的复合年增长率预计为 5.2%。

美国市场预估26亿美元，中国预期复合年增长率7.4%

预计2023年美国冠状动脉支架市场规模将达26亿美元。中国作为世界第二大经济体，预计2030年市场规模将达11亿美元，2023-2030年分析期间复合年增长率为7.4%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.4% 和 4.8%。在欧洲，德国预计复合年增长率为 5.0%。

全球冠状动脉支架市场 - 主要趋势和驱动因素总结

冠状动脉支架是可扩张的小管，插入狭窄或阻塞的冠状动脉以恢復心臟的血流。这些设备在冠状动脉疾病 (CAD) 的治疗中发挥重要作用，冠状动脉疾病是全球发病和死亡的主要原因。血管成形术（使用球囊扩张动脉）等手术后，支架有助于维持动脉畅通。冠状动脉支架包括裸金属支架（BMS）、药物释放型支架（DES）和生物可吸收支架。药物释放型支架涂有防止动脉血管再阻塞的药物，生物可吸收支架支撑动脉后逐渐溶解。

冠状动脉支架的发展和演变是由医疗技术和材料科学的进步所推动的。早期的裸金属支架提供结构支撑，但血管再阻塞的风险很高。药物释放型支架的引入透过释放抑制疤痕组织生长的抗增殖药物显着降低了这种风险。最近的发展包括生物可吸收支架的开发，该支架可以暂时支撑支架然后溶解，这可能会减少长期併发症。支架设计的创新，例如更薄的支柱和更高的灵活性，改善了支架的输送和性能，使其更安全、更有效。此外，诊断影像技术的进步提高了支架置入的准确性并改善了患者的治疗结果。

冠状动脉支架市场的成长受到多种因素的推动。首先，由于人口老化、不健康的生活方式以及肥胖和糖尿病的增加等因素，冠状动脉疾病的盛行率不断增加，推动了对支架的需求。其次，支架技术的进步，例如下一代药物释放型和生物可吸收支架的开发，正在提高安全性和有效性，推动市场成长。第三，新兴国家不断扩大的医疗基础设施和先进医疗服务的普及正在增加冠状动脉支架的采用。此外，患者和医疗保健提供者对微创手术治疗 CAD 益处的认识不断提高，正在推动市场扩张。最后，政府支持政策、医疗保健资金和报销框架正在推动先进支架技术的采用，确保更好的患者治疗并推动市场成长。

受访企业范例（60家知名企业）

  • Abbott Cardiovascular
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biosensors International Group Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • Elixir Medical Corporation
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Microport Scientific Corporation
  • Sahajanand Medical Technologies Ltd.
  • Terumo Europe NV
  • Translumina GmbH

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-1148

Global Coronary Stents Market to Reach US$13.0 Billion by 2030

The global market for Coronary Stents estimated at US$8.9 Billion in the year 2023, is expected to reach US$13.0 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Drug Eluting Stents, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$9.2 Billion by the end of the analysis period. Growth in the Other Types segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 7.4% CAGR

The Coronary Stents market in the U.S. is estimated at US$2.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 7.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Coronary Stents Market - Key Trends & Drivers Summarized

Coronary stents are small, expandable tubes that are inserted into narrowed or blocked coronary arteries to restore blood flow to the heart. These devices play a crucial role in the treatment of coronary artery disease (CAD), which is a leading cause of morbidity and mortality worldwide. Stents help to keep the arteries open after procedures such as angioplasty, where a balloon is used to widen the artery. There are different types of coronary stents, including bare-metal stents (BMS), drug-eluting stents (DES), and bioresorbable stents. Drug-eluting stents are coated with medication that helps prevent the re-narrowing of the artery, while bioresorbable stents gradually dissolve after providing support to the artery.

The development and evolution of coronary stents have been driven by advancements in medical technology and materials science. Early bare-metal stents provided structural support but were associated with a higher risk of restenosis, or re-narrowing of the artery. The introduction of drug-eluting stents significantly reduced this risk by releasing antiproliferative drugs that inhibit the growth of scar tissue. More recently, bioresorbable stents have been developed to provide temporary support and then dissolve, potentially reducing long-term complications. Innovations in stent design, such as thinner struts and enhanced flexibility, have improved the deliverability and performance of stents, making them safer and more effective. Furthermore, advances in imaging and diagnostic technologies have enhanced the precision of stent placement, improving patient outcomes.

The growth in the coronary stent market is driven by several factors. Firstly, the increasing prevalence of coronary artery disease, driven by factors such as aging populations, unhealthy lifestyles, and rising rates of obesity and diabetes, is boosting the demand for stents. Secondly, advancements in stent technology, including the development of next-generation drug-eluting stents and bioresorbable stents, are driving market growth by offering improved safety and efficacy. Thirdly, the expansion of healthcare infrastructure and access to advanced medical treatments in emerging economies is increasing the adoption of coronary stents. Additionally, the growing awareness among patients and healthcare providers about the benefits of minimally invasive procedures for treating CAD is supporting market expansion. Lastly, supportive government policies, healthcare funding, and reimbursement frameworks are facilitating the adoption of advanced stent technologies, ensuring better patient care and driving market growth.

Select Competitors (Total 60 Featured) -

  • Abbott Cardiovascular
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biosensors International Group Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • Elixir Medical Corporation
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Microport Scientific Corporation
  • Sahajanand Medical Technologies Ltd.
  • Terumo Europe N.V.
  • Translumina GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Coronary Artery Disease (CAD) - A Perspective
    • Types of Coronary Stents
    • Competitive Scenario
    • Players Bet Heavily on Product Advances to Stay Competitive on Coronary Stents Market
    • Coronary Stents - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Global Market Prospects and Outlook
    • Global Coronary Stents Market Remains Hale & Hearty with Incredible Vigor
    • Drug-Eluting Stents: Segment at the Heart of Global Coronary Stents Market
    • Decent Contribution from Bioresorbable Scaffolds & Bare Metal Stents
    • North America Rules Coronary Stents Market, while Asia-Pacific Pumps Growth Boosters
    • China's Effective Treatments' Clinical Trials in Progress to Augment the Market Size
    • Market Restraints & Challenges
    • Market Opportunities
    • Technological Advancements
    • Product Launches
    • Strategic Collaborations
    • Rising Popularity of Drug-Eluting Stents
    • Focus on Personalized Medicine
    • The Medical Tourism Trend
    • Relocation of Manufacturing Operations to Low-cost Countries
    • Recent Market Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Unprecedented Spike in CAD Cases Drives the Demand for Coronary Stents
    • Global Annual Medical Cost of CVD in the United States: 2015-2030
    • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Ageing Demographics and Longer Life Expectancy Bolsters Market Growth
    • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • The Rise in Minimally Invasive Surgeries Spur Market Expansion
    • Rising Middle Class Population Aids Growth
    • Global Middle Class Population (in Millions) by Geographic Region: 2010, 2020E & 2030P
    • Rising Healthcare Expenditure: Opportunities in Store
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
    • Risk of CAD in Obesity Offers Prospects for Coronary Stenting
    • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
    • Diabetics at Higher Risk of Heart Diseases to Propel Market Demand
    • Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040
    • New Drug-Eluting Stent for Treatment of Diabetic People with Coronary Heart Disease
    • The Hypertension-Cholesterol Link to Drive the Demand for Coronary Stents
    • Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
    • Growing Awareness Levels
    • Uptake of Advanced Imaging Techniques
    • Supportive Reimbursement Policies
    • Innovative Device with Potential to Take Coronary Stent Technology to Next Level
    • New Nitric Oxide-Producing Stent Coatings to Prevent Thrombosis and Restenosis
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Coronary Stents Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • JAPAN
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • CHINA
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • EUROPE
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Coronary Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • FRANCE
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • GERMANY
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Coronary Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • INDIA
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 134: Middle East Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Middle East Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Middle East 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 137: Middle East Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Middle East Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Middle East 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030
  • AFRICA
    • Coronary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 140: Africa Recent Past, Current & Future Analysis for Coronary Stents by Type - Drug Eluting Stents and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Africa Historic Review for Coronary Stents by Type - Drug Eluting Stents and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Africa 16-Year Perspective for Coronary Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents and Other Types for the Years 2014, 2024 & 2030
    • TABLE 143: Africa Recent Past, Current & Future Analysis for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Africa Historic Review for Coronary Stents by End-user - Hospitals, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Africa 16-Year Perspective for Coronary Stents by End-user - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Users for the Years 2014, 2024 & 2030

IV. COMPETITION